Nuo Therapeutics, Inc. (AURX) › RevenueNuo Therapeutics, Inc. (AURX) — RevenueAnnual figures by period end, from SEC filings.2017-12-31: $721.0K2018-12-31: $1.37M2019-12-31: $146.2K2020-12-31: $02021-12-31: $02022-12-31: $112.2K2023-12-31: $608.5K2024-12-31: $1.37M2025-12-31: $3.31M$3.31M2017-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$3.31M+142.7%2026-03-30From 2025-01-012024-12-31$1.37M+124.3%2026-03-30From 2024-01-012023-12-31$608.5K+442.1%2025-04-01From 2023-01-012022-12-31$112.2K—2024-04-19From 2022-01-012021-12-31$0—2023-04-17From 2021-01-012020-12-31$0-100.0%2022-04-15From 2020-01-012019-12-31$146.2K-89.3%2022-04-15From 2019-01-012018-12-31$1.37M+90.1%2019-04-16From 2018-01-012017-12-31$721.0K—2019-04-16From 2017-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)